1. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1262,
2000,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
2. |
The past, present and future of meningococcal vaccines |
|
Inpharma Weekly,
Volume &NA;,
Issue 1262,
2000,
Page 3-4
Giles Brooke,
Preview
|
|
摘要:
Meningococcal disease, usually manifesting as bacteraemia or meningitis, is a frequently fatal infection caused by the bacteriumNeisseria meningitidis.It has attracted substantial media attention in the Western world because of recent epidemics in several developed countries. At the 40th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) [Toronto, Canada; September 2000], delegates were treated to good news concerning the efficacy of the meningococcal group C conjugate vaccines recently launched in the UK, and detailed accounts of the progress in developing vaccines against meningococcal serotypes A and B that are effective in all age groups. Tantalisingly, early preclinical studies in the UK suggest that a cross-reactive vaccine with universal protective efficacy, i.e. against all serotypes, may be possible.
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
3. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1262,
2000,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
4. |
Aspirin + dipyridamolevsaspirin top value for stroke prevention |
|
Inpharma Weekly,
Volume &NA;,
Issue 1262,
2000,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
5. |
Intensive chemotherapy causes distress, but treatment worthwhile |
|
Inpharma Weekly,
Volume &NA;,
Issue 1262,
2000,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
6. |
PEG IFN-α-2b + ribavirin effective in chronic hepatitis C |
|
Inpharma Weekly,
Volume &NA;,
Issue 1262,
2000,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
7. |
Optimising immunotherapy for malignant melanoma |
|
Inpharma Weekly,
Volume &NA;,
Issue 1262,
2000,
Page 9-10
Rachael Pepperle,
Preview
|
|
摘要:
The increasing incidence of malignant melanoma in European populations and the promise of new immunotherapies have provided impetus to the field of melanoma research. Metastatic melanoma is rarely curable, but chemotherapy and/or immunotherapy may increase the time to disease progression and the survival duration. Patients with resectable disease who are at high risk of relapse may receive adjuvant immunotherapy, with the primary aim of preventing recurrence. Results from 3 randomised phase III trials in patients with melanoma were presented at the 25th Congress of the European Society of Medical Oncology [Hamburg, Germany; October 2000], 2 of which were included as conference highlights in the Presidential Symposium.
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
8. |
Manipulating energy expenditure: potential in obesity |
|
Inpharma Weekly,
Volume &NA;,
Issue 1262,
2000,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
9. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1262,
2000,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
10. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1262,
2000,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|